Aniara Diagnostica recalls BIOPHEN LMWH Control C4 (REF 22420: Lots F1701555P4) due to incorrect Instructions for Use packaging. Consumers should check their product lot numbers.
The manufacturer packaged incorrect versions of the Instructions for Use into specific lots for three device product codes.
Aniara Diagnostica is recalling specific lots of BIOPHEN LMWH Control C4 blood tests because the manufacturer packaged incorrect instructions for use. This could lead to improper use if someone follows the wrong instructions.
The manufacturer included incorrect Instructions for Use in specific product lots. This means users might follow the wrong instructions, potentially leading to improper blood test results.
People who own or use the recalled BIOPHEN LMWH Control C4 blood tests with lot number F1701555P4 are affected. Those using the product for medical testing are most at risk of incorrect usage.
Check the product lot number on the BIOPHEN LMWH Control C4 packaging. The recalled lot is F1701555P4. This product was sold with the reference number REF 224201.
Look for the lot number on the BIOPHEN LMWH Control C4 packaging to confirm if it's the recalled lot F1701555P4.
The recalled lot number is F1701555P4.
Check the lot number on the packaging; if it's F1701555P4, it's affected.
The recall record does not specify a remedy, so no action is required beyond checking the lot number.
We’ve drafted a message you can send Aniara Diagnostica to request your refund or repair — edit it as you like.
Subject: Recall Z-1190-2019 — Aniara Diagnostica Aniara Diagnostica Hello, I own a Aniara Diagnostica that is covered by recall Z-1190-2019 from Aniara Diagnostica. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
